Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prevest DenproBOM:543363 +0.78%84 Days Payable is 57.59 as of Mar. 2026, which is 1% below its 10-year median of 58.04. GuruFocus rates BOM:543363 with a GF Score™ of 84/100 and a GF Value™ of ₹622.13 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Prevest Denpro ranks worse than 70.4% on this metric.
The historical rank and industry rank for Prevest Denpro's Days Payable or its related term are showing as below:
BOM:543363'
s Days Payable Range Over the Past 10 Years
Min: 32.12 Med: 58.04 Max: 122.26
Current: 45.48
During the past 8 years, Prevest Denpro's highest Days Payable was 122.26. The lowest was 32.12. And the median was 58.04.
BOM:543363's Days Payable is ranked worse than 70.4% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs BOM:543363: 45.48
Prevest Denpro's Days Payable
increased
from Mar. 2025 (37.89) to Mar. 2026 (57.59).
It may suggest that Prevest Denprodelayed paying its suppliers.
Prevest Denpro Days Payable Related Terms
Prevest Denpro Days Payable Historical Data
* Premium members only.
The historical data trend for Prevest Denpro's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543363 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Prevest Denpro's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prevest Denpro Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Prevest Denpro's Days Payable distribution charts can be found below:
* The bar in red indicates where Prevest Denpro's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Prevest Denpro's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prevest Denpro (BOM:543363) has a Days Payable of 57.59 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Prevest Denpro and its competitors. This is near median its historical median of 58.04. Over the past decade, Prevest Denpro's Days Payable has ranged from 32.12 to 122.26. According to the industry distribution chart, Prevest Denpro ranks #559 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 70.4%.
Is Prevest Denpro's Days Payable too high?
Prevest Denpro's current Days Payable of 57.59 is near median its 10-year median of 58.04. Over the past 10 years, this metric has ranged from a low of 32.12 to a high of 122.26. The Medical Devices & Instruments industry median Days Payable is 67.85. Prevest Denpro's value of 57.59 is 15.1% below this industry median. Based on the distribution chart, Prevest Denpro ranks #559 out of 794 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Prevest Denpro has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prevest Denpro's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prevest Denpro ranks #559 out of 794 companies for Days Payable. This places Prevest Denpro in the lower half of its industry. The industry median Days Payable is 67.85. Prevest Denpro's value of 57.59 is 15.1% below this benchmark. Historically, Prevest Denpro's own Days Payable has ranged from 32.12 to 122.26 over the past decade. While the company's 10-year median is 58.04 vs. the industry median of 67.85, Prevest Denpro has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prevest Denpro's current Days Payable of 57.59 is 15.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Prevest Denpro and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prevest Denpro's current Days Payable is 57.59, which is near median its own 10-year median of 58.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prevest Denpro stock overvalued right now?
Based on GuruFocus' analysis, Prevest Denpro (BOM:543363) is currently considered Possible Value Trap. The stock's GF Value™ is ₹622.13, compared to a current price of ₹390.00 — trading 37.3% below its estimated fair value. The current Days Payable is 57.59, which is near median its 10-year median of 58.04 and 15.1% below the Medical Devices & Instruments industry median of 67.85. Prevest Denpro's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Prevest Denpro (BOM:543363), the current Days Payable is 57.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prevest Denpro (BOM:543363) Overvalued in 2026?
Based on GuruFocus' analysis, Prevest Denpro stock appears to be undervalued.
The current stock price of ₹390.00 is trading 37.3% below its estimated GF Value™ of ₹622.13.
GuruFocus considers Prevest Denpro to be Possible Value Trap.
Key valuation signals for BOM:543363:
Days Payable: 57.59 (near median its 10-year median of 58.04)
GF Value™: ₹622.13 vs. price of ₹390.00 (37.3% below fair value)
Industry Position: 15.1% below the Medical Devices & Instruments median (#559 of 794)
No single metric tells the full story. See the BOM:543363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prevest Denpro Ltd develops, manufactures and markets a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The company's product portfolio covers wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
84GF Score
Get the complete analysis for BOM:543363
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543363 has been successfully added to your 
